Editorial (Thematic Issue: Biosafety of Viral Vectors Commonly Used in Gene Therapy and Vaccination)

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|13|6|383-384

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.13, Iss.6, 2013-12, pp. : 383-384

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

General Considerations on the Biosafety of Virus-derived Vectors Used in Gene Therapy and Vaccination

By  

Current Gene Therapy, Vol. 13, Iss. 6, 2013-12 ,pp. : 385-394

Bentham Science Publishers

Access to resources Recommend Favorite

Biosafety Challenges for Use of Lentiviral Vectors in Gene Therapy

By  

Current Gene Therapy, Vol. 13, Iss. 6, 2013-12 ,pp. : 453-468

Bentham Science Publishers

Access to resources Recommend Favorite

Biosafety Considerations Using Gamma-Retroviral Vectors in Gene Therapy

By  

Current Gene Therapy, Vol. 13, Iss. 6, 2013-12 ,pp. : 469-477

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphonolipids as non-viral vectors for gene therapy

By Floch V.   Le Bolc'h G.   Gable-Guillaume C.   Le Bris N.   Yaouanc J.-J.   des Abbayes H.   Ferec C.   Clement J.-C.  

European Journal of Medicinal Chemistry, Vol. 33, Iss. 12, 1998-12 ,pp. : 923-934

Elsevier

Access to resources Recommend Favorite

Viral Vectors for Gene-Directed Enzyme Prodrug Therapy

By  

Current Gene Therapy, Vol. 6, Iss. 6, 2006-12 ,pp. : 647-670

Bentham Science Publishers

Access to resources Recommend Favorite